Rhumbline Advisers Precigen, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q4 2024

A detailed history of Rhumbline Advisers transactions in Precigen, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 197,134 shares of PGEN stock, worth $335,127. This represents 0.0% of its overall portfolio holdings.

Number of Shares

197,134

Previous 183,796 7.26%

Holding current value

$335,127

Previous $174,000 26.44%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	BUY	$0.67 - $1.12 $8,936 - $14,938	13,338 Added 7.26%	197,134 $220,000
Q3 2024 Nov 12, 2024	SELL	$0.91 - $1.88 $17,194 - $35,522	-18,895 Reduced 9.32%	183,796 $174,000
Q2 2024 Aug 01, 2024	SELL	$1.27 - $1.75 $566 - $780	-446 Reduced 0.22%	202,691 $320,000
Q1 2024 May 09, 2024	SELL	$1.21 - $1.75 $5,884 - $8,510	-4,863 Reduced 2.34%	203,137 $294,000
Q4 2023 Feb 08, 2024	SELL	$0.89 - $1.41 $938 - $1,486	-1,054 Reduced 0.5%	208,000 $278,000
Q3 2023 Nov 09, 2023	BUY	$1.08 - $1.85 $9,001 - $15,419	8,335 Added 4.15%	209,054 $296,000
Q2 2023 Aug 08, 2023	BUY	$0.96 - $1.4 $24,322 - $35,470	25,336 Added 14.45%	200,719 $230,000
Q1 2023 May 11, 2023	BUY	$0.88 - $2.19 $19,082 - $47,490	21,685 Added 14.11%	175,383 $186,000
Q4 2022 Feb 14, 2023	BUY	$1.27 - $2.26 $8,454 - $15,044	6,657 Added 4.53%	153,698 $234,000
Q3 2022 Nov 10, 2022	BUY	$1.41 - $2.79 $19,026 - $37,648	13,494 Added 10.1%	147,041 $312,000
Q2 2022 Aug 11, 2022	BUY	$1.15 - $2.53 $40,252 - $88,555	35,002 Added 35.52%	133,547 $179,000
Q1 2022 May 12, 2022	SELL	$1.91 - $3.98 $2,828 - $5,894	-1,481 Reduced 1.48%	98,545 $208,000
Q4 2021 Feb 10, 2022	SELL	$3.53 - $5.5 $7,303 - $11,379	-2,069 Reduced 2.03%	100,026 $371,000
Q3 2021 Nov 12, 2021	BUY	$4.99 - $6.55 $18,647 - $24,477	3,737 Added 3.8%	102,095 $509,000
Q2 2021 Aug 05, 2021	BUY	$6.24 - $8.22 $53,645 - $70,667	8,597 Added 9.58%	98,358 $641,000
Q1 2021 May 06, 2021	SELL	$6.74 - $10.95 $44,989 - $73,091	-6,675 Reduced 6.92%	89,761 $618,000
Q4 2020 Feb 10, 2021	BUY	$3.75 - $10.56 $27,131 - $76,401	7,235 Added 8.11%	96,436 $984,000
Q3 2020 Nov 12, 2020	SELL	$3.5 - $6.2 $44,345 - $78,554	-12,670 Reduced 12.44%	89,201 $312,000
Q2 2020 Aug 13, 2020	SELL	$2.16 - $5.46 $21,708 - $54,873	-10,050 Reduced 8.98%	101,871 $508,000
Q1 2020 May 06, 2020	BUY	$1.46 - $7.19 $163,404 - $804,711	111,921 New	111,921 $381,000

Others Institutions Holding PGEN

# of Institutions

143

Shares Held

161M

Call Options Held

232K

Put Options Held

69K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $354M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Precigen, Inc. Transaction History